Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Case of a 6-Year-Old Girl With a Rare Compound Heterozygous Mutation of Kctd7 Presenting With Progressive Myoclonic Epilepsy Publisher



Badv RS1 ; Shariatmadari F1, 2 ; Bayat S3 ; Memarian S1 ; Esteghamat Hanzae S1 ; Yousefimanesh H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatrics Center of Excellence, Department of Pediatric Neurology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pediatric Neurology, Arak University of Medical Sciences, Arak, Iran
  3. 3. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Egyptian Journal of Medical Human Genetics Published:2024


Abstract

Background: Progressive myoclonic epilepsy is a clinically and genetically heterogeneous group of diseases characterized by myoclonic seizures, drug-resistant epilepsy and neurodevelopmental regression. The disease is attributed to mutations in KCTD7 (a member of the potassium channel tetramerization domain). Case presentation: We report the case of a 6-year-old girl with compound heterozygous mutation in KCTD7. Whole-exome sequencing was carried out to detect the mutations followed by Sanger sequencing of the patient in addition to the unaffected parents which confirmed the diagnosis. The first mutation [c. 202A > G (p.Thr68Ala)] was inherited from mother and the second one [c. 458G > A (p.Arg153His)] was inherited from father. Conclusions: To our knowledge, this is the first report of compound heterozygousKCTD7-related progressive myoclonic epilepsy in Iran with c.202A > G in particular as a novel mutation. Our findings widen the scope of our knowledge of the underlying genetic etiology of the aforementioned disease which can further help us in the genetic diagnosis of these patients. © The Author(s) 2024.